PNC Financial Services Group’s AbbVie ABBV Stock Holding History

PNC Financial Services Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01B	Sell	4,007,446 -107,520	-3%	-$23.1M	0.5%	34
2026 Q1	$895M	Sell	4,114,966 -27,973	-0.7%	-$6.21M	0.52%	33
2025 Q4	$947M	Sell	4,142,939 -152,493	-4%	-$34.7M	0.52%	32
2025 Q3	$995M	Buy	4,295,432 +209,476	+5%	+$42.7M	0.6%	28
2025 Q2	$758M	Sell	4,085,956 -52,243	-1%	-$9.71M	0.49%	39
2025 Q1	$867M	Sell	4,138,199 -4,123	-0.1%	-$802K	0.45%	29
2024 Q4	$736M	Sell	4,142,322 -196,325	-5%	-$36.1M	0.49%	37
2024 Q3	$857M	Sell	4,338,647 -16,836	-0.4%	-$3.14M	0.55%	31
2024 Q2	$747M	Sell	4,355,483 -72,858	-2%	-$12.1M	0.5%	34
2024 Q1	$806M	Sell	4,428,341 -301,962	-6%	-$52M	0.56%	29
2023 Q4	$733M	Sell	4,730,303 -45,777	-1%	-$6.67M	0.58%	30
2023 Q3	$712M	Sell	4,776,080 -37,045	-0.8%	-$5.44M	0.61%	28
2023 Q2	$648M	Sell	4,813,125 -95,751	-2%	-$14M	0.55%	36
2023 Q1	$782M	Sell	4,908,876 -29,854	-0.6%	-$4.56M	0.69%	25
2022 Q4	$798M	Sell	4,938,730 -21,257	-0.4%	-$3.26M	0.77%	21
2022 Q3	$666M	Sell	4,959,987 -66,266	-1%	-$9.51M	0.7%	26
2022 Q2	$770M	Sell	5,026,253 -75,458	-1%	-$11.5M	0.76%	22
2022 Q1	$827M	Sell	5,101,711 -77,932	-2%	-$11.3M	0.72%	22
2021 Q4	$701M	Buy	5,179,643 +190,109	+4%	+$22.5M	0.58%	33
2021 Q3	$538M	Sell	4,989,534 -155,912	-3%	-$17.8M	0.5%	44
2021 Q2	$580M	Sell	5,145,446 -11,822	-0.2%	-$1.33M	0.53%	39
2021 Q1	$558M	Sell	5,157,268 -78,130	-1%	-$8.36M	0.54%	37
2020 Q4	$561M	Sell	5,235,398 -33,787	-0.6%	-$3.25M	0.57%	30
2020 Q3	$462M	Buy	5,269,185 +11,781	+0.2%	+$1.11M	0.57%	38
2020 Q2	$516M	Buy	5,257,404 +456,877	+10%	+$40.2M	0.69%	30
2020 Q1	$366M	Buy	4,800,527 +703,269	+17%	+$59.9M	0.46%	41
2019 Q4	$363M	Sell	4,097,258 -12,223	-0.3%	-$1.01M	0.36%	62
2019 Q3	$311M	Sell	4,109,481 -46,360	-1%	-$3.18M	0.31%	66
2019 Q2	$302M	Sell	4,155,841 -74,806	-2%	-$5.88M	0.3%	70
2019 Q1	$341M	Sell	4,230,647 -658,509	-13%	-$53.9M	0.34%	62
2018 Q4	$451M	Sell	4,889,156 -72,849	-1%	-$6.41M	0.5%	39
2018 Q3	$469M	Sell	4,962,005 -219,985	-4%	-$20.9M	0.45%	40
2018 Q2	$480M	Sell	5,181,990 -30,622	-0.6%	-$2.99M	0.47%	36
2018 Q1	$493M	Sell	5,212,612 -31,616	-0.6%	-$3.47M	0.49%	35
2017 Q4	$507M	Buy	5,244,228 +450,898	+9%	+$42.5M	0.49%	33
2017 Q3	$426M	Buy	4,793,330 +3,078	+0.1%	+$234K	0.44%	42
2017 Q2	$347M	Buy	4,790,252 +95,788	+2%	+$6.44M	0.37%	60
2017 Q1	$306M	Sell	4,694,464 -39,037	-0.8%	-$2.45M	0.34%	63
2016 Q4	$296M	Sell	4,733,501 -66,169	-1%	-$4.04M	0.34%	58
2016 Q3	$303M	Sell	4,799,670 -38,795	-0.8%	-$2.51M	0.35%	60
2016 Q2	$300M	Sell	4,838,465 -63,411	-1%	-$3.86M	0.35%	59
2016 Q1	$280M	Sell	4,901,876 -21,750	-0.4%	-$1.21M	0.33%	67
2015 Q4	$292M	Sell	4,923,626 -192,671	-4%	-$11.1M	0.34%	61
2015 Q3	$278M	Buy	5,116,297 +152,117	+3%	+$9.9M	0.33%	63
2015 Q2	$334M	Sell	4,964,180 -25,474	-0.5%	-$1.66M	0.37%	51
2015 Q1	$292M	Sell	4,989,654 -155,250	-3%	-$9.38M	0.32%	61
2014 Q4	$337M	Sell	5,144,904 -76,957	-1%	-$4.85M	0.37%	54
2014 Q3	$302M	Buy	5,221,861 +873,046	+20%	+$48.5M	0.36%	53
2014 Q2	$245M	Sell	4,348,815 -183,655	-4%	-$9.63M	0.31%	59
2014 Q1	$233M	Sell	4,532,470 -104,580	-2%	-$5.29M	0.31%	60
2013 Q4	$245M	Sell	4,637,050 -204,926	-4%	-$10.1M	0.32%	59
2013 Q3	$217M	Sell	4,841,976 -122,100	-2%	-$5.41M	0.32%	65
2013 Q2	$205M	Buy	+4,964,076	New	+$217M	0.3%	62

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PNC Financial Services Group's ABBV Position: Q2 2026 in Review

PNC Financial Services Group reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $23.1M and leaving 4,007,446 shares worth $1.01B. The position accounts for 0.5% of the portfolio, ranked #34.

PNC Financial Services Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PNC Financial Services Group held 4,007,446 shares of AbbVie worth $1.01B as of Q2 2026.
PNC Financial Services Group sold 107,520 AbbVie shares in Q2 2026, an estimated $23.1M.
AbbVie made up 0.5% of PNC Financial Services Group's portfolio in Q2 2026, its #34 holding.
PNC Financial Services Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.